Zhenfeng Guan

277 Yanta West Road
Xi'an, 710061, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Establishment and validation of a predictive model for bone metastasis in prostate cancer patients based on multiple immune inflammatory parameters.

Establishment and validation of a predictive model for bone metastasis in prostate cancer patients based on multiple immune inflammatory parameters.

Journal: American journal of translational research

Published: November 18, 2022

Tenascin-C promotes bladder cancer progression and its action depends on syndecan-4 and involves NF-κB signaling activation.

Tenascin-C promotes bladder cancer progression and its action depends on syndecan-4 and involves NF-κB signaling activation.

Journal: BMC cancer

Published: October 12, 2021

MiR-1273 g-3p Promotes Malignant Progression and has Prognostic Implications in Prostate Cancer.

MiR-1273 g-3p Promotes Malignant Progression and has Prognostic Implications in Prostate Cancer.

Journal: Molecular biotechnology

Published: February 03, 2021

Bladder cancer cells interact with vascular endothelial cells triggering EGFR signals to promote tumor progression.

Bladder cancer cells interact with vascular endothelial cells triggering EGFR signals to promote tumor progression.

Journal: International journal of oncology

Published: August 21, 2018

Knock-down of DAB2 interacting protein (DAB2IP) promotes proliferation and inhibits apoptosis of bladder cancer cells

Knock-down of DAB2 interacting protein (DAB2IP) promotes proliferation and inhibits apoptosis of bladder cancer cells

Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology

Published: May 16, 2017

Silibinin suppresses bladder cancer cell malignancy and chemoresistance in an NF-κB signal-dependent and signal-independent manner.

Silibinin suppresses bladder cancer cell malignancy and chemoresistance in an NF-κB signal-dependent and signal-independent manner.

Journal: International journal of oncology

Published: May 03, 2017

Synthesis of a cell penetrating peptide modified superparamagnetic iron oxide and MRI detection of bladder cancer.

Synthesis of a cell penetrating peptide modified superparamagnetic iron oxide and MRI detection of bladder cancer.

Journal: Oncotarget

Published: May 18, 2016

Androgen receptor (AR) signaling promotes RCC progression via increased endothelial cell proliferation and recruitment by modulating AKT → NF-κB → CXCL5 signaling.

Androgen receptor (AR) signaling promotes RCC progression via increased endothelial cell proliferation and recruitment by modulating AKT → NF-κB → CXCL5 signaling.

Journal: Scientific reports

Published: April 14, 2016

NF-κB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression.

NF-κB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression.

Journal: International journal of oncology

Published: August 16, 2015

HIF-1α/MDR1 pathway confers chemoresistance to cisplatin in bladder cancer.

HIF-1α/MDR1 pathway confers chemoresistance to cisplatin in bladder cancer.

Journal: Oncology reports

Published: August 16, 2015

G9a Inhibition Induces Autophagic Cell Death via AMPK/mTOR Pathway in Bladder Transitional Cell Carcinoma.

G9a Inhibition Induces Autophagic Cell Death via AMPK/mTOR Pathway in Bladder Transitional Cell Carcinoma.

Journal: PloS one

Published: June 29, 2015

Inhibiting bladder tumor growth with a cell penetrating R11 peptide derived from the p53 C-terminus.

Inhibiting bladder tumor growth with a cell penetrating R11 peptide derived from the p53 C-terminus.

Journal: Oncotarget

Published: April 20, 2015

Showing 1-12 of 20

Last Updated: 09/26/2026